OR WAIT null SECS
© 2023 MJH Life Sciences and BioPharm International. All rights reserved.
© 2023 MJH Life Sciences™ and BioPharm International. All rights reserved.
March 15, 2023
A phase-appropriate analytical development strategy is crucial, especially for complex (formulated) drug substances.
March 01, 2023
Considerable efforts have been made over the years to resolve the key issues of stability and delivery of RNA-based therapeutics.
January 31, 2023
Big data is a natural for pharmaceutical industry players that have not already embraced it.
January 11, 2023
Advanced LC technologies can streamline the review process for LC equipment maintenance.
January 02, 2023
Affinity chromatography resins must perform well under mild elution conditions yet withstand robust cleaning and sanitization protocols.
January 01, 2023
Biologic drug development requires relevant bioassays to measure and help predict cellular response.
December 19, 2022
The launch of Discovery Life Sciences’ new Proteomic Services Division offers a single source for large-scale population studies, biobank characterization, and multi-omic biomarker analysis.
December 02, 2022
The design of viral clearance studies must keep pace with the quickly evolving biologic drugs industry.
November 21, 2022
Biotech startup, Cradle, has raised $5.4 million in seed funding with an AI-enabled design platform that allows for the synthetic building of cell factories to produce proteins.
November 08, 2022
An orthogonal approach to lipid nanoparticle analysis is recommended to optimize drug development success.